API
< Back to situations

[ORGANIZATION]

National Supplementary Health Agency

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [IT]

GLP-1 receptor agonist research and safety scrutiny

13 clusters · 72 sources · last updated

Latest: GLP-1 medications face scrutiny over vision loss risks and clinical developments

Research into GLP-1 receptor agonists (GLP-1 RAs) has expanded to investigate health benefits beyond glycemic control and weight loss, specifically regarding bone health, pain, and inflammation. Studies involving adults

Also covered in